Protocol Ledger

NCT06766916 · Phase II · RECRUITING

Crisugabalin for Radiotherapy-Related Neuropathic Pain

Interventional Phase II clinical trial protocol NCT06766916 sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-05-07 Enrollment: 172 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06766916
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)172 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06766916
Protocol FieldVerified Registry Value
NCT IdentifierNCT06766916
Consolidated Lead SponsorSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment172 participants (ESTIMATED)
Registered Start Date2025-05-07
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI